Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 12 ($0.15) and last traded at GBX 13 ($0.16), with a volume of 24529 shares traded. The stock had previously closed at GBX 12.86 ($0.16).
Celadon Pharmaceuticals Stock Up 1.1 %
The firm has a market capitalization of £8.95 million, a PE ratio of -156.25 and a beta of -0.26. The company has a debt-to-equity ratio of 194.82, a quick ratio of 6.97 and a current ratio of 1.92. The firm’s 50-day moving average is GBX 28.75 and its 200 day moving average is GBX 52.70.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Which Wall Street Analysts are the Most Accurate?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Options Trading – Understanding Strike Price
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
